Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform ...

Track Scopus Biopharma Inc (SCPS) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money ...

Benitec Biopharma Limited (BNTC) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ...

Revenue: US$18.5m (up 2.6% from 3Q 2024). Net income: US$3.94m (up from US$2.89m loss in 3Q 2024). Profit margin: 21% (up from net loss in 3Q 2024). EPS: US$0.64 (up from US$0.52 loss in 3Q 2024 ...

GT Biopharma completed dosing in Cohort 1 and began Cohort 2 of its Phase 1 trial for GTB-3650 with no safety concerns. Early data shows increased NK cell activity, indicating promising immune ...

Quantum BioPharma Ltd. has announced that Unbuzzd Wellness Inc., the company behind the innovative unbuzzd™ beverage aimed at enhancing alcohol metabolism and reducing hangover symptoms ...

The traditional biopharma approach focused primarily on physician detailing and securing favorable payer contracts, has become inadequate in today’s market. The healthcare ecosystem has undergone a ...

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a ...

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company ...

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of ...

Quantum BioPharma Ltd. has announced an agreement with a global pharmaceutical contract research organization to prepare an Investigational New Drug (IND) application package for Lucid-21-302 ...